Archil Jaliashvili: Hemopure and the Future of Oxygen Delivery in Severe Bleeding
Archil Jaliashvili, Co-owner, General Manager of SkinAI, Co-Chief Executive Officer at GeoBio Pharm, shared a post on LinkedIn:
”A patient with catastrophic hemorrhage survived after Cleveland Clinic used Hemopure, when conventional blood transfusion was not an option.
For decades, we spoke about ‘blood substitutes.’
But the real medical target was never blood itself.
The target is oxygen delivery.
We should not only manage hemoglobin numbers.
We must manage tissue oxygenation.
The future of transfusion medicine will not be only about blood.
It will be about precision oxygen delivery.
For emerging BHOC biological hemoglobin oxygen carrier biosimilar and new-generation platforms, this is another important real-world signal that the field is evolving toward solving major global unmet medical needs:
- Severe hemorrhage
- Trauma and emergency care
- Battlefield medicine
- Maternal bleeding
- Organ preservation and perfusion
- Veterinary critical care
- Remote and disaster medicine
Sometimes one clinical case says more than a thousand theoretical discussions.”
Stay updated with Hemostasis Today.
-
Aug 31, 2026, 05:19Tania Ahuja: Apixaban in Abdominal Transplant Patients
-
Aug 31, 2026, 04:28Reza Hafidz Irawan։ Automated Antibody Titration With Erytra Eflexis
-
Aug 31, 2026, 04:17Safa Chenganath: Stenosis vs Thrombosis – Hemodialysis Vascular Access
-
Aug 30, 2026, 17:13J. Meireles-Brandao: Hypertension, Inflammation and Lipoprotein Disease
-
Aug 30, 2026, 17:10Hugh Nguyen: Leading the New Era of Blood Services Across Asia Pacific
-
Aug 30, 2026, 17:09Transforming Childhood Through Access to Hemophilia Treatment – World Federation of Hemophilia
-
Aug 30, 2026, 17:07Raj Bharath: Connecting Clinicians and Researchers to Advance Transfusion Medicine
-
Aug 30, 2026, 17:04Rana Al Hrout: Free FRCPath Haematology Part 1 Exam Preparation Session
-
Aug 30, 2026, 17:02David McGlasson: A 2020 Article Reaches 8,000 Reads